Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Global Post-CDK4/6 Treatment Line Oncology Drugs Market Report: Precision Oncology, Treatment Innovation and Growth ProspectsAccording to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market CAGR Value The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The...0 Комментарии 0 Поделились 214 Просмотры 0 предпросмотр
-
How Is Demand for Precision Oncology Supporting the Asia-Pacific Tumor Ablation Market?According to the latest report published by Data Bridge Market Research, the Asia-Pacific Tumor Ablation Market CAGR Value The Asia-Pacific tumor ablation market size was valued at USD 2.36 billion in 2025 and is expected to reach USD 5.61 billion by 2033, at a CAGR of 11.45% during the forecast period The reliable Asia-Pacific Tumor Ablation Market research report includes...0 Комментарии 0 Поделились 336 Просмотры 0 предпросмотр
-
Hyper Personalized Medicine Market Advances Through Precision Oncology ApplicationsThe global Hyper Personalized Medicine Market is rapidly evolving as emerging technologies enable healthcare providers to deliver highly targeted therapies tailored to individual biological characteristics. According to Polaris Market Research, the market reached USD 2,256.42 billion in 2023 and is forecast to grow to USD 6,333.03 billion by 2032, expanding at a CAGR of 12.2%. The increasing...0 Комментарии 0 Поделились 433 Просмотры 0 предпросмотр
-
NUT Midline Carcinoma Treatment Market Outlook: Growing Adoption of Precision Medicine in OncologyThe NUT Midline Carcinoma Treatment Market is gaining attention as advancements in molecular diagnostics, targeted therapies, and precision oncology continue to transform the management of rare and aggressive cancers. NUT midline carcinoma (NMC) is an uncommon cancer caused primarily by genetic alterations involving the NUTM1 gene, leading to uncontrolled tumor growth. Due to its aggressive...0 Комментарии 0 Поделились 605 Просмотры 0 предпросмотр
-
Oral HER Pathway Targeted Drugs Market Expands with Advances in Precision Oncology" According to the latest report published by Data Bridge Market Research, the Oral HER Pathway Targeted Drugs Market CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period The reliable Oral HER...0 Комментарии 0 Поделились 334 Просмотры 0 предпросмотр
-
Radiation Oncology Treatment Planning Software Market Advances With Demand for Precision Cancer Care" According to the latest report published by Data Bridge Market Research, the Radiation Oncology Treatment Planning Software Market CAGR Value Data Bridge Market Research analyses that the radiation oncology treatment planning software market which was USD 2.18 billion in 2022, would rocket up to USD 4.34 billion by 2030, and is expected to undergo a CAGR of 9.00% during the...0 Комментарии 0 Поделились 38 Просмотры 0 предпросмотр
-
Why Is Precision Oncology Driving the North America Prostate Cancer Diagnostics Market?According to the latest report published by Data Bridge Market Research, the North America Prostate Cancer Diagnostics Market CAGR Value The North America prostate cancer diagnostics market size was valued at USD 2.53 billion in 2024 and is expected to reach USD 6.67 billion by 2032, at a CAGR of 12.90% during the forecast period Winning North America Prostate Cancer Diagnostics...0 Комментарии 0 Поделились 162 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek